197a.T
197A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.
Business. 197A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.
Analyst recommendations
2 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
197A.T is a Japanese medical equipment and supplies company that generates revenue primarily through the sale of healthcare products and services.
197A.T maintains a liquidity position with a current ratio of 1.62, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -872.97 million JPY, and capital expenditures are substantial at -5.12 billion JPY, suggesting significant reinvestment in operations. The debt-to-equity ratio of 0.83 indicates a moderate level of leverage, with long-term debt amounting to 14.42 billion JPY against total equity of 17.42 billion JPY.
The company's profitability is strong, with a return on equity of 36.26% and a return on assets of 17.3%, both exceeding typical industry benchmarks for medical equipment and supplies firms. Operating income of 8.24 billion JPY and net income of 6.32 billion JPY reflect a healthy margin structure, although gross profit of 12.77 billion JPY suggests a relatively high cost of goods sold.
197A.T's revenue is not segmented by geographic region or product line in the available data, but the company's exposure is likely concentrated in Japan given its domestic listing and the absence of international revenue breakdowns. This lack of diversification could pose a risk if domestic demand fluctuates or if regulatory changes impact the healthcare sector in Japan.
The company's growth trajectory is not explicitly outlined in the available data, but the current revenue of 18.63 billion JPY and the substantial capital expenditures suggest a strategy of expansion or modernization. Analysts have provided a mean price target of 450.00 JPY, with a median of 450.00 JPY, indicating a generally stable outlook.
Risk factors for 197A.T include a medium liquidity risk due to a negative net cash position after subtracting total debt, and a low dilution risk as indicated by the risk assessment. The company's capital structure and financial flexibility may be constrained by its high capital expenditures and negative free cash flow, which could limit its ability to invest in new opportunities or respond to market changes.
Recent events and filings for 197A.T are not detailed in the available data, but the company's financial performance and analyst estimates suggest a stable but not particularly dynamic business environment. The absence of strong buy or buy recommendations from analysts indicates a cautious outlook, with one hold recommendation and no strong sell or sell recommendations.
- 197A.T has a strong return on equity and assets, indicating efficient use of capital and assets.
- The company's liquidity position is moderate, with a current ratio of 1.62 but negative free cash flow.
- 197A.T's capital expenditures are substantial, suggesting a focus on expansion or modernization.
- Analysts have a generally stable outlook for the company, with a mean price target of 450.00 JPY.
- The company's risk profile is characterized by medium liquidity risk and low dilution risk.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 53,84 |
| Revenue | —no estimate | —no estimate | 14,8B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 197A.T Market data — financials · 2026-05-26
- Tauns Laboratories Inc Market data — analyst estimates · 2026-05-26